Abionyx Pharma (France) Probability of Future Stock Price Finishing Under 0.06
| ABNX Stock | EUR 1.22 0.03 2.40% |
Abionyx |
Abionyx Pharma Target Price Odds to finish below 0.06
The tendency of Abionyx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to € 0.06 or more in 90 days |
| 1.22 | 90 days | 0.06 | near 1 |
Based on a normal probability distribution, the odds of Abionyx Pharma to drop to € 0.06 or more in 90 days from now is near 1 (This Abionyx Pharma SA probability density function shows the probability of Abionyx Stock to fall within a particular range of prices over 90 days) . Probability of Abionyx Pharma SA price to stay between € 0.06 and its current price of €1.22 at the end of the 90-day period is about 16.23 .
Assuming the 90 days trading horizon Abionyx Pharma has a beta of 0.34. This suggests as returns on the market go up, Abionyx Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Abionyx Pharma SA will be expected to be much smaller as well. Additionally Abionyx Pharma SA has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Abionyx Pharma Price Density |
| Price |
Predictive Modules for Abionyx Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Abionyx Pharma SA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Abionyx Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Abionyx Pharma is not an exception. The market had few large corrections towards the Abionyx Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Abionyx Pharma SA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Abionyx Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.34 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.06 |
Abionyx Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Abionyx Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Abionyx Pharma SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Abionyx Pharma SA generated a negative expected return over the last 90 days | |
| Abionyx Pharma SA may become a speculative penny stock | |
| The company reported the revenue of 675 K. Net Loss for the year was (5.82 M) with profit before overhead, payroll, taxes, and interest of 259 K. | |
| Abionyx Pharma SA has accumulated about 8.33 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38. | |
| Roughly 32.0% of the company shares are held by company insiders |
Abionyx Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Abionyx Stock often depends not only on the future outlook of the current and potential Abionyx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abionyx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.6 M | |
| Cash And Short Term Investments | 7.9 M |
Abionyx Pharma Technical Analysis
Abionyx Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Abionyx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Abionyx Pharma SA. In general, you should focus on analyzing Abionyx Stock price patterns and their correlations with different microeconomic environments and drivers.
Abionyx Pharma Predictive Forecast Models
Abionyx Pharma's time-series forecasting models is one of many Abionyx Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Abionyx Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Abionyx Pharma SA
Checking the ongoing alerts about Abionyx Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Abionyx Pharma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Abionyx Pharma SA generated a negative expected return over the last 90 days | |
| Abionyx Pharma SA may become a speculative penny stock | |
| The company reported the revenue of 675 K. Net Loss for the year was (5.82 M) with profit before overhead, payroll, taxes, and interest of 259 K. | |
| Abionyx Pharma SA has accumulated about 8.33 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38. | |
| Roughly 32.0% of the company shares are held by company insiders |
Other Information on Investing in Abionyx Stock
Abionyx Pharma financial ratios help investors to determine whether Abionyx Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abionyx with respect to the benefits of owning Abionyx Pharma security.